Aqua Medical has received investigational device exemption (IDE) from the FDA for its ablation device aimed at treating ...
FDA recently issued the draft guidance, Quality Management System Information for Certain Premarket Submission Reviews. The guidance is designed ...
Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.
The FDA has approved the Tendyne device to replace the mitral heart valve through a small incision between the ribs. Dr. Paul ...
In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now ...
Incyte today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual Meeting, to be ...
UniQure , said on Monday its experimental gene therapy for Huntington's disease does not have adequate clinical data to ...